Mono Pharmacare Profit & Loss Annual

BSE: - | NSE: MONOPHARMA | ISIN: INE0OIP01012 | Sector: -

24.30 - (-4.89%)Updated : 14 Jul 2025

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Total Operating Expense	116.13	55.61	35.81	27.55
Other Net	-0.14	0.03	0.03	0.10
Total Adjustmentsto Net Income	0.00	-	-	-
Diluted Weighted Average Shares	1.54	1.77	1.77	1.77
Depreciation/ Amortization	0.12	0.10	0.11	0.13
Operating Income	6.21	2.86	1.17	0.72
Net Income	2.44	1.23	0.35	0.10
Income Availableto Com Excl Extra Ord	2.44	1.23	0.35	0.10
Other Operating Expenses Total	1.82	1.07	0.39	0.32
Net Income Before Taxes	3.23	1.68	0.55	0.17
Minority Interest	-0.02	0.00	0.00	0.00
Net Income After Taxes	2.46	1.23	0.35	0.10
Income Availableto Com Incl Extra Ord	2.44	1.23	0.35	0.10
Costof Revenue Total	110.68	53.34	34.69	26.56
Gross Profit	11.66	5.14	2.29	1.71
Interest Inc( Exp) Net- Non- Op Total	-2.85	-1.22	-0.65	-0.64
Unusual Expense( Income)	0.00	0.00	0.00	0.00
Diluted Net Income	2.44	1.23	0.35	0.10
Provisionfor Income Taxes	0.77	0.44	0.20	0.07
period Type	-	-	-	-
Net Income Before Extra Items	2.44	1.23	0.35	0.10
Total Revenue	122.34	58.48	36.98	28.27
period Length	12.00	12.00	12.00	12.00
Revenue	122.34	58.48	36.98	28.27
Selling/ General/ Admin Expenses Total	3.51	1.10	0.62	0.54
Diluted Normalized EPS	1.59	0.70	0.20	0.05
Diluted EPS Excluding Extra Ord Items	1.59	0.70	0.20	0.05

*All figures in crores except per share values

1,717.80+35.75(2.13%)

881.90+14.75(1.70%)

258.45+4.30(1.69%)

1,566.10-53.85 (-3.32%)

159.50-0.85 (-0.53%)

Related News